The «DNA-Technology» was founded in 1993. It has consolidated the experience of leading researches of NRC «Institute for High Energy Physics» and «NRC Institute of Immunology » Federal Medical-Biological Agency of Russia. Our Company is the only domestic manufacturer of the full technological cycle - from scientific development to equipping and supporting medical laboratories with equipment and PCR kits for carrying out molecular genetic studies using the Real-time PCR method. The products quality is confirmed by international certification (ISO 13485: 2016, 9001: 2015, CE IVD-certificates), which allows the company to develop local and international markets (45 international distributors worldwide). Besides of the full range of routine studies for diagnosis of human infectious diseases, «DNA-Technology» offers for use the following unique inventions (more than 25 patents): - innovative studies of the microbiome composition of the reproductive tract of men and women (Femoflor®, Androflor®, ImmunoQuantex ®); - determination of genetic predisposition to various diseases, including cancer risk (BRCA 1, 2 mutations, polymorphisms of hemostasis system genes, etc.); - HLA class II genotyping; - non-invasive prenatal diagnosis of fetal DNA, RHD genotyping and sex determination of fetus, - pharmacogenetics research (sensitivity to anticoagulation therapy and antiplatelet agents); - detection of viral and bacterial infections such as Hepatitis and HIV; urogenital infections; herpesvirus infections; human papillomavirus infections; respiratory tract infections; especially dangerous and natural focal infections; other infections;
As part of the development of science-intensive technologies, the company cooperates with Russians and International scientific and clinical centers. Some unique developments of "DNA-Technology» won prestigious awards such as national award to best medicine professionals “The Calling”, 2014, Prix Galien Russia, 2016 and etc.